The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
9400/9750 and hopefully that's the drop done for this month:
https://twitter.com/quakes99/status/1762232402896896311
It's now up and running, but not seeing any trades on google finance yet
https://www.google.com/finance/quote/URNJ:LON
New discussion board here:
https://www.lse.co.uk/ShareChat.html?ShareTicker=URNJ
HL already supported RTW, and that's what they've converted my Arix to, which is fine.
Fidelity didn't support either, and has converted to RTWG, which is not fine. Why? Because RTWG is thinly traded, and has a spread to match. Today I can sell 10,000 RTW with HL for 104.39p, but for Fidelity/RTWG I'm only offered 102p.
Perhaps Fidelity thought they were doing us a favour by choosing the £-denominated version, but it certainly isn't working out that way, for now at least.
Https://www.thearmchairtrader.com/yellow-cake-soars-as-governments-go-nuclear/
More about this:
https://www.proactiveinvestors.co.uk/companies/news/1041318/hanetf-founder-and-co-ceo-talks-about-new-junior-uranium-miners-etf-future-of-defence-and-bitcoin-1041318.html
"... will list this Friday ... probably the most asked-for ETF I've ever had ..."
Estimated NAV/share is $1.88, so the current SP is at about 31% discount.
According to HL the 12 month average discount to NAV is about 25% which would put the SP at $1.41, so we might reasonably expect a drift up towards this as the sell-off abates.
Https://www.youtube.com/watch?v=yxNhu4-j0D0
IG interviewing Tom Bailey of HanETF.
NB he says they'll be introducing a URNJ equivalent ETF at the end of February.
...and still waiting.
Pleased to see this in today's valuation RNS:
"The Company intends to publish, at the soonest opportunity, an indicative and estimated pro forma NAV and NAV per share as at the closing date of the Transaction, reflecting the completion of the Transaction and new share issuance."
Also pleased to see they've ramped up the buy-back to take advantage of the ex-Arix sell-off. That's been more severe than I was expecting, given that many people won't even have the new shares yet. (But it doesn't alter the thesis that RTW holders should have taken the opportunity to sell and buy Arix shares instead!)
Not yet (HL & Fidelity).
New RNS:
https://www.londonstockexchange.com/news-article/RTW/completion-of-acquisition/16330014
Https://www.londonstockexchange.com/news-article/RTW/update-on-arix-transaction/16329111
2nd vote passed as expected (97.84%)
https://www.londonstockexchange.com/news-article/ARIX/scheme-effective/16328759
I, for one, welcome our new RTW overlords.
Final comparison:
RTW(Bid) $1.38 x 1.4633 x 79.2p/$ = 159.9p ARIX
or perhaps more usefully now:
ARIX 143p / 79.2p/$ / 1.4633 = $1.234 RTW
$1.38 = $1.234 + 11.8%
No significant impact yet on the RTW SP, but let's see what happens tomorrow when the new shares arrive on the scene.
Moving over to the RTW board now I suppose. See you all there? GLA